Epicore Biosystems, Inc. — Form D/A
Epicore Biosystems, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2025-04-07. The offering totals $35.0M, of which $25.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-07
- Form: D/A
- Accession: 0001755876-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $25.7M
- Remaining: $9.3M
- Investors: 4
- Date of first sale: 2024-12-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-534274
Issuer
- Name: Epicore Biosystems, Inc.
- CIK: 0001755876
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 410 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139
- Phone: 8575297776
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Roozbeh Ghaffari | Director | Cambridge, MA |
| Laura Lang | Director | Cambridge, MA |
| Kimberly Querrey | Director | New York, NY |
| John Rogers | Director | CHICAGO, IL |
| Alexander J Aranyosi | Executive Officer | Cambridge, MA |
| Roozbeh Ghaffari | Executive Officer | Cambridge, MA |
| Stephen Lee | Executive Officer | CHICAGO, IL |
| Weihua J Li | Executive Officer | Cambridge, MA |
| Jeffrey J Model | Executive Officer | Cambridge, MA |
| James J Ryan | Executive Officer | Cambridge, MA |
| John Wright | Executive Officer | Calgary, A0 |
| JAMES RYAN | Executive Officer | ITASCA, IL |
| John Rogers | Executive Officer | CHICAGO, IL |
| JEFF MODEL | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (5)
More